Sepsis Detection Made Rapid and Accurate with Dr. Rolland Carlson CEO of Immunexpress

Join us with guest Dr. Rolland Carlson, CEO of Immunexpress to talk about the transformative work happening in sepsis diagnosis. Dr. Carlson discusses the importance of rapid sepsis diagnosis. The episode covers challenges faced during product development, regulatory achievements, and future plans for sepsis diagnostics. Dr. Carlson also shares advice on ensuring product quality and navigating FDA clearances.00:00 Introduction to From Lab to Launch00:25 Meet Dr. Rolland Carlson, CEO of Immunexpress01:31 Challenges and Innovations in Sepsis Diagnosis03:01 Impact of COVID-19 on Clinical Trials04:17 The Vision Behind Septicite Rapid05:17 Technical Insights into Sepsis Diagnosis14:00 Regulatory Achievements and Quality Management16:58 Integrating Septicite Rapid in Clinical Workflows24:00 Future Innovations in Sepsis Diagnostics25:34 A Personal Note from Dr. Carlson26:29 Conclusion and Farewellhttps://immunexpress.com/ https://www.linkedin.com/in/rollie-carlson-ph-d-059074a/  Qualio website:https://www.qualio.com/Previous episodes:https://www.qualio.com/from-lab-to-launch-podcastApply to be on the show:https://forms.gle/uUH2YtCFxJHrVGeL8Music by keldez